1. Ulbright TM, Amin MB, Balzer B, Derney DM, Epstein JI, Guo C, Idrees MT, Looijenga LHJ, Paner G, Rajpert-De Meyts E, Skakkebaek NE, Tickoo SK, Yilmaz A, Oosterhuis JW (2016) Germ cell tumours. In: Moch HP, Ulbright TM, Reuter V (eds) WHO classification of tumours of the urinary system and male genital organs. IARC Press, Lyon, pp 189–198
2. Rajpert-De Meyts E, McGlynn KA, Okamoto K, Jewett MA, Bokemeyer C (2016) Testicular germ cell tumours. Lancet 387(10029):1762–1774
3. Albany C, Einhorn LH (2013) Extragonadal germ cell tumors: clinical presentation and management. Curr Opin Oncol 25(3):261–265
4. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I et al (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3):379–391
5. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE et al (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63(9):2244–2250